BeOne Medicines Income Statement (2015-2026) | ONC

Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
206.44M213.98M306.63M341.57M387.63M380.10M447.80M595.26M781.31M634.41M751.65M929.17M1,001.60M1,127.82M1,117.28M1,315.30M1,412.28M1,498.17M1,513.44M1,705.07M
Cost of Revenue (Quarter)
47.41M48.55M65.24M71.17M76.54M73.52M81.79M95.99M96.31M105.83M124.94M138.13M170.46M160.56M165.00M164.61M196.51M142.42M167.22M174.53M
Gross Profit (Quarter)
159.03M165.43M241.39M270.40M311.08M306.57M366.01M499.27M685.00M528.58M626.72M791.03M831.14M967.26M952.28M1,150.69M1,215.77M1,355.75M1,346.22M1,530.54M
Operating items
Amortization - Intangibles (Quarter)
0.40M0.82M1.02M1.00M0.99M0.97M0.99M1.03M2.27M2.96M1.18M1.18M
Research & Development (Quarter)
351.94M-556.29M389.92M378.21M426.36M446.02M408.58M422.76M453.26M493.99M460.64M454.47M496.18M542.01M481.89M524.90M523.66M615.42M541.22M612.28M
Selling, General & Administrative (Quarter)
269.23M-479.65M294.57M331.40M322.89M329.74M328.50M395.03M365.71M418.38M427.43M443.73M455.22M504.68M459.29M537.91M529.00M555.29M555.10M593.21M
Other Operating Expenses (Quarter)
47.60M-116.92M65.42M71.36M76.73M-213.52M0.19M0.19M
Operating Expenses (Quarter)
668.76M-1152.86M749.91M780.97M825.99M562.24M737.27M817.99M818.97M912.37M888.07M898.20M951.40M1,046.69M941.17M1,062.81M1,052.66M1,170.71M1,096.32M1,205.49M
Operating Income (Quarter)
-462.32M190.56M-443.29M-439.40M-438.36M-468.62M-371.26M-318.71M-133.97M-383.80M-261.35M-107.16M-120.27M-79.42M11.10M87.89M163.11M185.03M249.90M325.05M
EBIT (Quarter)
-462.32M190.56M-443.29M-439.40M-438.36M-468.62M-371.26M-318.71M-133.97M-383.80M-261.35M-107.16M-120.27M-79.42M11.10M87.89M163.11M185.03M249.90M325.05M
Non-operating items
Interest & Investment Income (Quarter)
12.85M27.66M27.90M
Other Non Operating Income (Quarter)
31.48M-800.16M11.97M-129.62M-125.64M19.44M18.30M-63.82M336.66M16.75M1.76M-11.98M11.32M-13.73M3.95M8.17M-18.98M-35.69M14.54M-0.75M
Non Operating Income (Quarter)
26.65M16.27M16.16M13.22M10.64M7.81M5.85M3.50M3.03M
Net income details
EBT (Quarter)
-433.08M-606.03M-421.25M-557.59M-551.24M-430.96M-336.94M-367.46M229.34M-350.77M-243.43M-105.92M-98.30M-85.35M20.90M99.55M147.16M149.24M259.21M312.46M
Tax Provisions (Quarter)
5.04M-15.35M13.95M8.14M6.32M14.37M11.49M13.67M13.93M16.78M7.72M14.48M23.05M66.53M19.63M5.23M22.32M82.74M31.86M75.45M
Profit After Tax (Quarter)
-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M237.01M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)
-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M237.01M
Consolidated Net Income (Quarter)
-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M237.01M
Income towards Parent Company (Quarter)
-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M237.01M
Net Income towards Common Stockholders (Quarter)
-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M237.01M
Additional items
EPS (Basic) (Quarter)
-0.36-0.49-0.33-0.42-0.41-0.33-0.26-0.280.16-0.27-0.19-0.09-0.09-0.110.000.070.090.050.160.16
EPS (Diluted) (Quarter)
-0.36-0.49-0.33-0.42-0.41-0.33-0.26-0.280.15-0.27-0.19-0.09-0.09-0.110.000.060.080.050.150.16
Shares Outstanding (Quarter)
1,205.97M1,206.21M1,332.02M1,336.46M1,345.30M1,340.73M1,354.16M1,360.22M1,360.72M1,357.03M1,355.55M1,361.08M1,376.75M1,368.75M1,390.05M1,408.17M1,432.80M1,417.80M1,442.45M1,450.49M
Shares Outstanding (Diluted) (Quarter)
1,205.97M1,206.21M1,332.02M1,336.46M1,345.30M1,340.73M1,354.16M1,360.22M1,390.33M1,357.03M1,355.55M1,361.08M1,376.75M1,368.75M1,445.25M1,463.28M1,488.75M1,474.83M1,505.03M1,505.36M
Shares Outstanding (Entity) (Quarter)
1,213.23M1,334.80M1,334.81M1,349.64M1,349.64M1,356.14M1,362.65M1,376.25M1,353.00M1,359.51M1,359.52M1,379.10M1,386.03M1,387.37M1,403.28M1,540.98M1,540.98M1,540.98M1,540.98M1,540.98M
EBITDA (Quarter)
-462.32M190.56M-443.29M-439.40M-438.36M-468.62M-371.26M-318.71M-133.97M-383.80M-261.35M-107.16M-120.27M-79.42M11.10M87.89M163.11M185.03M249.90M325.05M
Interest Expenses (Quarter)
7.61M7.08M6.62M5.46M5.60M8.20M5.02M4.89M6.63M12.09M12.40M13.23M14.31M16.06M12.96M12.05M12.65M20.57M32.89M39.74M
Tax Rate (Quarter)
-1.16%2.53%-3.31%-1.46%-1.15%-3.33%-3.41%-3.72%6.07%-4.78%-3.17%-13.68%-23.44%-77.95%93.92%5.25%15.17%55.44%12.29%24.15%